Neurotechnology company Synchron has successfully merged its brain-computer interface (BCI) with ChatGPT, significantly enhancing its usability. This integration allows individuals who are unable to move their limbs to communicate through their thoughts using a ChatGPT brain implant.
The device enables users to input text on various devices using their thoughts. According to CNET, it has assisted Mark, a patient with amyotrophic lateral sclerosis (ALS), in communicating with others.
As of now, Synchron’s implant has not yet received market approval from the US Food and Drug Administration. However, companies like Synchron and Neuralink are making strides in the development of BCI technology.
CNET interviewed Synchron CEO Tom Oxley to delve deeper into the ChatGPT brain implant. Oxley noted that composing messages word by word using a BCI can be a lengthy process.
By integrating GPT-4, OpenAI’s latest large language model, communication becomes faster and more efficient. The model predicts potential responses based on previous conversations, streamlining the communication process.
This advancement allows users to send replies with a single “click” instead of typing out each message. Additionally, implant user Mark mentioned that the device has become increasingly accurate in generating responses that reflect his likely replies.
Synchron installs the device using existing medical technologies such as stents, which are wire meshes used to keep blood vessels open.
The company employs its specialized stent, known as a “stentrode,” to place the ChatGPT brain implant inside a blood vessel near the brain’s motor cortex. As a result, the procedure does not require traditional surgery.
We have helped 20+ companies in industries like Finance, Transportation, Health, Tourism, Events, Education, Sports.
